Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Ophthalmic Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Ophthalmic Devices Market By Product Type
1.2.2.1. Global Ophthalmic Devices Market Revenue and Growth Rate Comparison By Product Type (2016-2027)
1.2.2.2. Global Ophthalmic Devices Market Revenue Share By Product Type in 2019
1.2.2.3. Ophthalmic Surgical Devices
1.2.2.3.1. Refractive Error Surgical Devices
1.2.2.3.1.1. Excimers and Femtosecond Lasers
1.2.2.3.1.2. Microkeratomes
1.2.2.3.2. Glaucoma Surgical Devices
1.2.2.3.2.1. Implants and Stents
1.2.2.3.2.2. Glaucoma Drainage
1.2.2.3.2.3. Glaucoma Laser Devices
1.2.2.3.3. Cataract Surgery Devices
1.2.2.3.3.1. Intraocular Lenses
1.2.2.3.3.2. Viscoelastics
1.2.2.3.3.3. Phacoemulsification Systems
1.2.2.3.4. Vitreoretinal Surgical Devices
1.2.2.3.4.1. Vitrectomy Machines & Vitrectomy Packs
1.2.2.3.4.2. Photocoagulation Lasers
1.2.2.3.4.3. Illumination Devices
1.2.2.4. Ophthalmic Diagnostic Devices
1.2.2.4.1. Refractors
1.2.2.4.2. Corneal Topography Systems
1.2.2.4.3. Retinal Ultrasound Systems
1.2.2.4.4. Fundus Camera
1.2.2.4.5. Ophthalmoscopes
1.2.2.4.6. Optical Coherence Tomography Systems
1.2.2.4.7. Perimeters
1.2.2.4.8. Slit Lamps
1.2.2.4.9. Tonometers
1.2.2.5. Ophthalmic Vision Care Devices
1.2.2.5.1. Contact Lenses
1.2.2.5.2. Spectacle Lenses
1.2.3. Ophthalmic Devices Market By Geography
1.2.3.1. Global Ophthalmic Devices Market Revenue and Growth Rate Comparison by Geography (2016-2027)
1.2.3.2. North America Ophthalmic Devices Market Revenue and Growth Rate(2016-2027)
1.2.3.3. Europe Ophthalmic Devices Market Revenue and Growth Rate(2016-2027)
1.2.3.4. Asia-Pacific Ophthalmic Devices Market Revenue and Growth Rate(2016-2027)
1.2.3.5. Latin America Ophthalmic Devices Market Revenue and Growth Rate(2016-2027)
1.2.3.6. Middle East and Africa (MEA)Ophthalmic Devices Market Revenue and Growth Rate(2016-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Ophthalmic Devices Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Ophthalmic Devices Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Ophthalmic Devices Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Ophthalmic Devices Major Manufacturers in 2019
CHAPTER 4. OPHTHALMIC DEVICES MARKET BY PRODUCT TYPE
4.1. Global Ophthalmic Devices Revenue By Product Type
4.2. Ophthalmic Surgical Devices
4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.2.3. Refractive Error Surgical Devices
4.2.3.1. Excimers and Femtosecond Lasers
4.2.3.2. Microkeratomes
4.2.4. Glaucoma Surgical Devices
4.2.4.1. Implants and Stents
4.2.4.2. Glaucoma Drainage
4.2.4.3. Glaucoma Laser Devices
4.2.5. Cataract Surgery Devices
4.2.5.1. Intraocular Lenses
4.2.5.2. Viscoelastics
4.2.5.3. Phacoemulsification Systems
4.2.6. Vitreoretinal Surgical Devices
4.2.6.1. Vitrectomy Machines & Vitrectomy Packs
4.2.6.2. Photocoagulation Lasers
4.2.6.3. Illumination Devices
4.3. Ophthalmic Diagnostic Devices
4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.3.3. Refractors
4.3.4. Corneal Topography Systems
4.3.5. Retinal Ultrasound Systems
4.3.6. Fundus Camera
4.3.7. Ophthalmoscopes
4.3.8. Optical Coherence Tomography Systems
4.3.9. Perimeters
4.3.10. Slit Lamps
4.3.11. Tonometers
4.4. Ophthalmic Vision Care Devices
4.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.4.3. Contact Lenses
4.4.4. Spectacle Lenses
CHAPTER 5. NORTH AMERICA OPHTHALMIC DEVICES MARKET BY COUNTRY
5.1. North America Ophthalmic Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.2. North America Ophthalmic Devices Market Revenue Share Comparison, 2016 & 2027 (%)
5.3. U.S.
5.3.1. U.S. Ophthalmic Devices Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
CHAPTER 6. EUROPE OPHTHALMIC DEVICES MARKET BY COUNTRY
6.1. Europe Ophthalmic Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.2. Europe Ophthalmic Devices Market Revenue Share Comparison, 2016 & 2027 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
CHAPTER 7. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET BY COUNTRY
7.1. Asia-Pacific Ophthalmic Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.2. Asia-Pacific Ophthalmic Devices Market Revenue Share Comparison, 2016 & 2027 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
CHAPTER 8. LATIN AMERICA OPHTHALMIC DEVICES MARKET BY COUNTRY
8.1. Latin America Ophthalmic Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. Latin America Ophthalmic Devices Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.4. Mexico
8.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
CHAPTER 9. MIDDLE EAST & AFRICA OPHTHALMIC DEVICES MARKET BY COUNTRY
9.1. Middle East & Africa Ophthalmic Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Middle East & Africa Ophthalmic Devices Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. GCC
9.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.4. South Africa
9.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.5. Rest of Middle East & Africa
9.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
CHAPTER 10. COMPANY PROFILE
10.1. Topcon Corporation
10.1.1. Company Snapshot
10.1.2. Overview
10.1.3. Financial Overview
10.1.4. Product Portfolio
10.1.5. Key Developments
10.1.6. Strategies
10.2. Novartis AG
10.2.1. Company Snapshot
10.2.2. Overview
10.2.3. Financial Overview
10.2.4. Product Portfolio
10.2.5. Key Developments
10.2.6. Strategies
10.3. Carl Zeiss Meditec AG
10.3.1. Company Snapshot
10.3.2. Overview
10.3.3. Financial Overview
10.3.4. Product Portfolio
10.3.5. Key Developments
10.3.6. Strategies
10.4. HAAG-Streit Holding AG
10.4.1. Company Snapshot
10.4.2. Overview
10.4.3. Financial Overview
10.4.4. Product Portfolio
10.4.5. Key Developments
10.4.6. Strategies
10.5. Johnson & Johnson
10.5.1. Company Snapshot
10.5.2. Overview
10.5.3. Financial Overview
10.5.4. Product Portfolio
10.5.5. Key Developments
10.5.6. Strategies
10.6. Nidek Co., Ltd.
10.6.1. Company Snapshot
10.6.2. Overview
10.6.3. Financial Overview
10.6.4. Product Portfolio
10.6.5. Key Developments
10.6.6. Strategies
10.7. Essilor International S.A.
10.7.1. Company Snapshot
10.7.2. Overview
10.7.3. Financial Overview
10.7.4. Product Portfolio
10.7.5. Key Developments
10.7.6. Strategies
10.8. Valeant Pharmaceuticals International, Inc.
10.8.1. Company Snapshot
10.8.2. Overview
10.8.3. Financial Overview
10.8.4. Product Portfolio
10.8.5. Key Developments
10.8.6. Strategies
10.9. Hoya Corporation
10.9.1. Company Snapshot
10.9.2. Overview
10.9.3. Financial Overview
10.9.4. Product Portfolio
10.9.5. Key Developments
10.9.6. Strategies
10.10. Others
10.10.1. Company Snapshot
10.10.2. Overview
10.10.3. Financial Overview
10.10.4. Product Portfolio
10.10.5. Key Developments
10.10.6. Strategies
CHAPTER 11. RESEARCH APPROACH
11.1. Research Methodology
11.1.1. Initial Data Search
11.1.2. Secondary Research
11.1.3. Primary Research
11.2. Assumptions and Scope
Rising incidences of chronic eye disorder across the globe, increase in number of in-patients suffering from various disorder such as cataracts, glaucoma, diabetic retinopathy are some factors expected to drive the growth of the global market.
The global ophthalmic devices market is anticipated to grow at a CAGR of around 6.2% during the forecasting period 2020 to 2027.
The global ophthalmic devices market size is expected to reach around US$ 60.0 Bn by 2027.
The cataract surgery devices segment is expected to account for significant revenue share in the global market.
The market in North America is expected to account for major revenue share owing to high patent pool suffering from eye disorder.
Asia Pacific is expected to witness faster growth in the near future owing to presence of major players operating in the country in this region.
The players profiled in the report Topcon Corporation, Novartis AG, Carl Zeiss Meditec AG, HAAG-Streit Holding AG, Johnson & Johnson, Nidek Co., Ltd., Essilor International S.A., Valeant Pharmaceuticals International, Inc., Hoya Corporation, Sonomed Escalon, FCI Ophthalmics, Glaukos Corporation, Ziemer Ophthalmic Systems AG, STAAR Surgical, and Gulden Ophthalmics.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date